Alternative formulations, delivery methods, and administration options for psychotropic medications in elderly patients with behavioral and psychological symptoms of dementia

2000, International Psychogeriatric Association. Behavioral and psychological symptoms of dementia (BPSD): A clinical and research update, 12, 1 Lyketsos, 2002, Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study, JAMA, 288, 1475, 10.1001/jama.288.12.1475 Yaffe, 2002, Patient and caregiver characteristics and nursing home placement in patients with dementia, JAMA, 287, 2090, 10.1001/jama.287.16.2090 Buhr, 2006, Caregivers' reasons for nursing home placement: Clues for improving discussion with families prior to the transition, Gerontologist, 46, 52, 10.1093/geront/46.1.52 Lebowitz, 2000, Behavioral and psychological symptoms of dementia (BPSD): A clinical and research update, Int Psychogeriatr, 12, 19, 10.1017/S1041610200006712 Finkel, 2000, Introduction to behavioural and psychological symptoms of dementia (BPSD), Int J Geriatr Psychiatry, 15, S2, 10.1002/(SICI)1099-1166(200004)15:1+<S2::AID-GPS159>3.0.CO;2-3 Schneider, 2006, Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease, N Engl J Med, 355, 1525, 10.1056/NEJMoa061240 Jeste, 2008, ACNP White Paper: Update on use of antipsychotic drugs in elderly persons with dementia, Neuropsychopharmacology, 33, 957, 10.1038/sj.npp.1301492 Salzman, 2008, Elderly patients with dementia-related symptoms of severe agitation and aggression: Consensus statement on treatment options, clinical trials methodology, and policy, J Clin Psychiatry, 69, 889, 10.4088/JCP.v69n0602 Cummings, 2006, Treatments for behavioural disorders in neurodegenerative diseases: Drug development strategies, Nat Rev Drug Discov, 5, 64, 10.1038/nrd1928 Sultzer, 2008, Clinical symptom responses to atypical antipsychotic medication in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial, Am J Psychiatry, 165, 844, 10.1176/appi.ajp.2008.07111779 Kales, 2007, Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications, Am J Psychiatry, 164, 1568, 10.1176/appi.ajp.2007.06101710 Kleijer, 2008, Risk of cerebrovascular events in elderly users of antipsychotics, J Psychopharmacol, 23, 909, 10.1177/0269881108093583 Knol, 2008, Antipsychotic drug use and risk of pneumonia in elderly people, J Am Geriatr Soc, 56, 661, 10.1111/j.1532-5415.2007.01625.x Schneider, 2005, Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials, JAMA, 294, 1934, 10.1001/jama.294.15.1934 Wang, 2005, Risk of death in elderly users of conventional vs. atypical antipsychotic medications, N Engl J Med, 353, 2335, 10.1056/NEJMoa052827 Pollock, 2007, A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia, Am J Geriatr Psychiatry, 15, 942, 10.1097/JGP.0b013e3180cc1ff5 Stubbs, 2008, Dickens G. Dose form modification—a common but potentially hazardous practice. A literature review and study of medication administration to older psychiatric inpatients, Int Psychogeriatr, 20, 616, 10.1017/S1041610207006047 Wright, 2002, Medication administration in nursing homes, Nurs Stand, 16, 33, 10.7748/ns2002.07.16.42.33.c3223 Treloar, 2000, A pill in the sandwich: Covert medication in food and drink, J R Soc Med, 93, 408, 10.1177/014107680009300805 Altamura, 1990, Clinical and toxicological profile of fluphenazine decanoate in elderly chronic schizophrenia, Int J Clin Pharmacol Res, 10, 223 Finkel, 1998, Psychotherapeutic agents in older adults. Antipsychotics: Old and new, Clin Geriatr Med, 14, 87, 10.1016/S0749-0690(18)30132-0 Forester, 2007, Report on an openlabel prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication, Am J Geriatr Pharmacother, 5, 209, 10.1016/j.amjopharm.2007.09.001 Laks, 2001, Efficacy and safety of risperidone oral solution in agitation associated with dementia in the elderly, Arq Neuropsiquiatr, 59, 859, 10.1590/S0004-282X2001000600005 Lasser, 2004, Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder, Int J Geriatr Psychiatry, 19, 898, 10.1002/gps.1184 Nelson, 2006, Mirtazapine orally disintegrating tablets in depressed nursing home residents 85 years of age and older, Int J Geriatr Psychiatry, 21, 898, 10.1002/gps.1589 Reeves, 2003, Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia, South Med J, 96, 699, 10.1097/01.SMJ.0000051066.55838.0A Yumru, 2006, Long-acting injectable risperidone for control of agitation in dementia, J Clin Psychiatry, 67, 1651, 10.4088/JCP.v67n1024d Geller, 1992, A practitioner's guide to use of psychotropic medication in liquid form, Hosp Community Psychiatry, 43, 969 Thompson, 1999, Nonenteral routes of administration for psychiatric medications. A literature review, Psychosomatics, 40, 185, 10.1016/S0033-3182(99)71234-X Müller, 2006, Attitudes toward different formulations of psychotropic drugs: The view of patients and healthcare providers, Am J Drug Deliv, 4, 33, 10.2165/00137696-200604010-00004 2008 2008 2009 2009 2009 2009, Drug Facts and Comparisons 2007 Aki, 2006, Evaluation of compatibility of risperidone with soft drinks and interactions of risperidone with tea tannin using isothermal titration microcalimetry, Jap J Pharmaceut Health Care Sci, 32, 190, 10.5649/jjphcs.32.190 Trissel, 2009 Meehan, 2002, Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: A double-blind, randomized study in acutely agitated patients with dementia, Neuropsychopharmacology, 26, 494, 10.1016/S0893-133X(01)00365-7 Barak, 2006, Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia, Am J Geriatr Psychiatry, 14, 629, 10.1097/01.JGP.0000216325.42721.99 Viukari, 1982, Tolerance and serum levels of haloperidol during parenteral and oral haloperidol treatment in geriatric patients, Acta Psychiatr Scand, 65, 301, 10.1111/j.1600-0447.1982.tb00850.x Raskind, 1979, Fluphenazine enanthate in the outpatient treatment of late paraphrenia, J Am Geriatr Soc, 27, 459, 10.1111/j.1532-5415.1979.tb01727.x Altamura, 2003, Intramuscular preparations of antipsychotics: Uses and relevance in clinical practice, Drugs, 63, 493, 10.2165/00003495-200363050-00004 Greenblatt, 1983, Drug therapy. Current status of benzodiazepines, N Engl J Med, 309, 410, 10.1056/NEJM198308183090705 Keith, 2006, Advances in psychotropic formulations, Prog Neuropsychopharmacol Biol Psychiatry, 30, 996, 10.1016/j.pnpbp.2006.03.031 Fraser, 2000, Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU, Pharmacotherapy, 20, 75, 10.1592/phco.20.1.75.34663 Regenold, 2001, Uses of intravenous valproate in geriatric psychiatry, Am J Geriatr Psychiatry, 9, 306, 10.1097/00019442-200108000-00017 Moukaddam, 2004, Intravenous antidepressants: A review, Depress Anxiety, 19, 1, 10.1002/da.10135 Yan, 2007, FDA warns of serious side effects from I.V. haloperidol, Psychiatr News, 42, 14, 10.1176/pn.42.21.0014a Tsai, 2002, Liquid risperidone in the treatment of psychotic agitation, CNS Drugs, 16, 777, 10.2165/00023210-200216110-00006 Gibson, 1991, Palatability of liquid major tranquilizers, Int J Geriatr Psychiatry, 6, 235, 10.1002/gps.930060408 Chan, 2008, Transdermal delivery of treatment for Alzheimer's disease: Development, clinical performance and future prospects, Drugs Aging, 25, 761, 10.2165/00002512-200825090-00003 Baghai, 2007, Selegiline transdermal system in the treatment of depressive disorders, Future Neurol, 2, 601, 10.2217/14796708.2.6.601 2009 Warren, 1996, Practical use of rectal medications in palliative care, J Pain Symptom Manage, 11, 378, 10.1016/0885-3924(96)00012-7 Dooley, 1998, Rectal use of benzodiazepines, Epilepsia, 39, S24, 10.1111/j.1528-1157.1998.tb05111.x Warren, 1996, Practical use of rectal medications in palliative care, J Pain Symptom Manage, 11, 378, 10.1016/0885-3924(96)00012-7 Koelle, 1998, Antidepressants for the virtually eviscerated patient: Options instead of oral dosing, Psychosom Med, 60, 723, 10.1097/00006842-199811000-00011 Hilty, 1998, Intravenous valproate for rapid stabilization of agitation in neuropsychiatric disorders, J Neuropsychiatry Clin Neurosci, 10, 365, 10.1176/jnp.10.3.365 Norman, 2004, New formulations of existing antidepressants: Advantages in the management of depression, CNS Drugs, 18, 505, 10.2165/00023210-200418080-00003 Masand, 2003, Long-acting injectable antipsychotics in the elderly, Drugs Aging, 20, 1099, 10.2165/00002512-200320150-00003 Howard, 1992, Which factors affect treatment response in late paraphrenia?, Int J Geriatr Psychiatry, 7, 667, 10.1002/gps.930070908 Glazer, 1992, Depot neuroleptic therapy: An underutilized treatment option, J Clin Psychiatry, 53, 426 Sink, 2005, Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence, JAMA, 293, 596, 10.1001/jama.293.5.596 Paradiso, 2008, Crushing or altering medications: What's happening in residential aged-care facilities?, Australas J Ageing, 21, 123, 10.1111/j.1741-6612.2002.tb00432.x James, 2004, The legal and clinical implications of crushing tablet medication, Nurs Times, 100, 28 Beckwith, 2004, A guide to drug therapy in patients with enteral feeding tubes: Dosage form selection and administration methods, Hosp Pharm, 39, 225, 10.1177/001857870403900308 Estoup, 1994, Approaches and limitations of medication delivery in patients with enteral feeding tubes, Crit Care Nurse, 14, 68, 10.4037/ccn1994.14.1.68 Guenter, 1999, Administering medications via feeding tubes: What consultant pharmacists need to know, Consult Pharm, 14 Mitchell, 2000, Oral dosage forms that should not be crushed: 2000 Update, Hosp Pharm, 35, 553 Haw, 2007, An observational study of medication administration errors in old-age psychiatric inpatients, Int J Qual Health Care, 19, 210, 10.1093/intqhc/mzm019 Bressler, 2006, Grapefruit juice and prescription drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs, Geriatrics, 61, 12 Kirkevold, 2005, Concealment of drugs in food and beverages in nursing homes: Cross sectional study, BMJ, 330, 20, 10.1136/bmj.38268.579097.55 Kirkevold, 2009, Is covert medication in Norwegian nursing homes still a problem? A cross-sectional study, Drugs Aging, 26, 333, 10.2165/00002512-200926040-00004 Wright, 2009, Consensus guideline on the medication management of adults with swallowing difficulties Williams, 2008, Medication administration through enteral feeding tubes, Am J Health-Syst Pharm, 65, 2347, 10.2146/ajhp080155 Heineck, 2009, Study on the use of drugs in patients with enteral feeding tubes, Pharm World Sci, 31, 145, 10.1007/s11096-008-9268-6 Lamnari, 2001, Point-Counterpoint: Is it ethical to give drugs to people with dementia? Yes: It is ethical if it is in their best interests, West J Med, 174, 228, 10.1136/ewjm.174.4.228 Treloar, 2001, Concealing medication in patients' food, Lancet, 357, 62, 10.1016/S0140-6736(00)03578-9 Honkanen, 2001, Point-Counterpoint: Is it ethical to give drugs covertly to people with dementia? No: Covert medication is paternalistic, West J Med, 174, 229, 10.1136/ewjm.174.4.229 Barnes, 2006, Making sure the residents get their tablets: Medication administration in care homes for older people, J Adv Nurs, 56, 190, 10.1111/j.1365-2648.2006.03997.x Lesar, 2002, Prescribing errors involving medication dosage forms, J Gen Intern Med, 17, 579, 10.1046/j.1525-1497.2002.11056.x